RankAlpha logo
Back to Rankings

AMGN

AmgenD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Bull: successful late-stage readouts, stable biologics demand, and continued buybacks drive EPS and multiple expansion toward the analyst high.
Posture
Defensive
Lead driver
Value
What changed
1 setup hits (3d) with net bullish as of 2026-10-24.
What can break
Biosimilar competition driving pricing/volume erosion
Momentum
93
Value
61
Sentiment
27
Setup hits (3d)
1 · Net Bullish
AI TargetsBase $333.98 · Bull $425.00 · Bear $180.00Analysis 2026-01-23; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-23 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-10-23

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions

Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Bullish
Target $403.61
Why
Momentum93 · Δ7d +5.0
Value61 · Δ7d -0.2
Sentiment27 · Δ7d -0.1
So what
Weak posture (Net Bullish). Prioritize risk control and patience.

Confirming evidence

  • • 1 setup hits (3d) with net bullish as of 2026-10-24.
  • • Value remains the lead driver in the composite, 7D delta -0.2.

Contradictions & invalidation

  • • Biosimilar competition driving pricing/volume erosion
  • • Disappointing capital-allocation actions or integration outcomes
  • • Bear: trial failures, accelerated biosimilar erosion, or adverse pricing/regulatory moves compress revenue and push valuation toward analyst lows.

Catalyst clock

2026-04-23

FY2025 Q4 earnings & guidance

Lead driver: Value · See fundamentals
Momentum
93
8% active weight
Current posture
7d trendFlat
Δ7d
+5.0
Δ21d
+31.3
Value
61
47% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
-1.1
Sentiment
27
45% active weight
Current posture
7d trendSoftening
Δ7d
-0.1
Δ21d
-12.7
Why this grade

Composite grade D. Momentum 93.4 / Value 61.3 / Sentiment 26.7

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-01-23. Scenario method

B+
Bull case
20%
Probability
Target price
$425.00
Analysis reference price unavailable
Analysis 2026-01-23 · RankAlpha Sentiment AI
Most likely
B
Base case
60%
Probability
Target price
$333.98
Analysis reference price unavailable
Analysis 2026-01-23 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$180.00
Analysis reference price unavailable
Analysis 2026-01-23 · RankAlpha Sentiment AI
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$237.48B
Beta
0.46
Shares Out
540.63M
P/E (TTM)
24.8
P/S (TTM)
4.80
P/FCF (TTM)
26.60
Rev YoY
+9.8%
EPS YoY
+64.9%
Gross Margin
+72.7%
Op Margin
+33.3%
Net Debt
$46.31B
Current Ratio
1.37
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data